https://www.nasdaq.com/press-release/alcoa-set-to-join-sp-midcap-400-2021-12-13
https://www.nasdaq.com/press-release/baxter-completes-acquisition-of-hillrom-creating-%2415-billion-global-medtech-leader
https://www.nasdaq.com/press-release/baxter-presents-data-at-ashp-meeting-indicating-machine-learning-may-enhance-infusion
https://www.nasdaq.com/press-release/hillrom-shareholders-approve-acquisition-by-baxter-2021-12-02
https://www.nasdaq.com/press-release/nuwellis-inc.-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-2021-11-19
https://www.nasdaq.com/press-release/baxter-declares-quarterly-dividend-2021-11-16
https://www.nasdaq.com/press-release/baxter-named-to-dow-jones-sustainability-indices-in-recognition-of-continued
https://www.nasdaq.com/press-release/baxter-announces-%24100-million-investment-in-biopharma-solutions-halle-westfalen
https://www.nasdaq.com/press-release/nuwellis-inc.-announces-third-quarter-2021-financial-results-2021-11-09
https://www.nasdaq.com/press-release/baxter-highlights-new-data-indicating-sharesource-digital-health-platform-for-home
https://www.nasdaq.com/press-release/aquadex-smartflowr-system-by-nuwellis-selected-as-a-2021-rd-100-awards-winner-2021-11
https://www.nasdaq.com/press-release/baxter-to-present-at-evercore-isi-4th-annual-healthconx-conference-2021-11-02
https://www.nasdaq.com/press-release/baxter-reports-third-quarter-2021-results-2021-10-28
https://www.nasdaq.com/press-release/baxter-and-biomerieux-announce-ce-mark-for-nephrocleartm-ccl14-test-to-predict
https://www.nasdaq.com/press-release/nuwellis-selected-as-a-recipient-of-the-governors-international-trade-award-2021-10
https://www.nasdaq.com/press-release/nuwellis-inc.-to-announce-third-quarter-2021-financial-results-on-november-9-2021
https://www.nasdaq.com/press-release/baxter-to-present-at-credit-suisse-30th-annual-virtual-healthcare-conference-2021-10
https://www.nasdaq.com/press-release/baxter-presents-critical-care-data-at-34th-annual-european-society-of-intensive-care
https://www.nasdaq.com/press-release/baxter-to-host-third-quarter-2021-financial-results-conference-call-for-investors
https://www.nasdaq.com/press-release/baxter-announces-u.s.-fda-approval-and-launch-of-ready-to-use-cardiovascular-medicine
https://www.nasdaq.com/press-release/nuwellis-receives-ce-mark-for-24-hour-blood-circuit-set-2021-09-21
https://www.nasdaq.com/press-release/nuwellis-inc.-announces-closing-of-%2410.0-million-underwritten-public-offering-of
https://www.nasdaq.com/press-release/nuwellis-inc.-announces-pricing-of-%248.7-million-underwritten-public-offering-of
https://www.nasdaq.com/press-release/nuwellis-inc.-announces-proposed-underwritten-public-offering-of-common-stock-2021-09
https://www.nasdaq.com/press-release/nuwellis-inc.-reports-an-inducement-grant-under-nasdaq-listing-rule-5635c4-2021-09-14
https://www.nasdaq.com/press-release/miromatrix-welcomes-dr.-john-barry-as-vice-president-of-research-and-development-2021
https://www.nasdaq.com/press-release/baxter-to-acquire-hillrom-expanding-connected-care-and-medical-innovation-globally
https://www.nasdaq.com/press-release/the-baxter-international-foundation-and-unicef-usa-announce-partnership-to-improve
https://www.nasdaq.com/press-release/baxter-advances-enterprise-digital-transformation-in-collaboration-with-aws-2021-08
https://www.nasdaq.com/press-release/baxter-to-present-at-ubs-genomics-2.0-and-medtech-innovations-summit-2021-07-29
https://www.nasdaq.com/press-release/cryolife-announces-sale-of-perclot-to-baxter-2021-07-29
https://www.nasdaq.com/press-release/baxter-announces-acquisition-of-perclot-polysaccharide-hemostatic-system-to-expand
https://www.nasdaq.com/press-release/baxter-reports-second-quarter-2021-results-2021-07-29
https://www.nasdaq.com/press-release/baxter-supports-analysis-demonstrating-clinical-and-economic-benefits-of-effective
https://www.nasdaq.com/press-release/baxter-declares-quarterly-dividend-2021-07-12
https://www.nasdaq.com/press-release/baxter-launches-new-2030-corporate-responsibility-commitment-to-advance-environmental
https://www.nasdaq.com/press-release/baxter-announces-%241.2-million-in-new-scholarships-and-grant-funding-to-support
https://www.nasdaq.com/press-release/hospital-iq-raises-%2425-million-to-meet-market-demand-for-its-software-which-optimizes
https://www.nasdaq.com/press-release/baxter-to-host-second-quarter-2021-financial-results-conference-call-for-investors
https://www.nasdaq.com/press-release/baxter-presents-data-at-58th-era-edta-congress-indicating-theranova-may-reduce
https://www.nasdaq.com/press-release/baxter-launches-the-sharesource-analytics-1.0-digital-health-module-to-enhance
https://www.nasdaq.com/press-release/baxter-launches-prismax-2-system-to-advance-critical-care-delivery-for-patients-and
https://www.nasdaq.com/press-release/baxter-to-present-at-the-ubs-global-healthcare-virtual-conference-2021-05-04
https://www.nasdaq.com/press-release/baxter-increases-dividend-and-declares-quarterly-dividend-2021-05-03
https://www.nasdaq.com/press-release/baxter-reports-first-quarter-2021-results-2021-04-29
https://www.nasdaq.com/press-release/chf-solutions-expands-commercial-focus-changes-name-to-nuwellis-2021-04-27
https://www.nasdaq.com/press-release/chf-solutions-expands-access-to-ultrafiltration-therapy-for-pediatric-patients-in-two
https://www.nasdaq.com/press-release/baxter-recognized-globally-for-inclusion-efforts-2021-04-21
https://www.nasdaq.com/press-release/baxter-receives-grant-from-german-federal-ministry-of-education-and-research-to-lead
https://www.nasdaq.com/press-release/chf-solutions-announces-first-patient-enrolled-in-the-ultra-peds-registry-2021-04-20
https://www.nasdaq.com/press-release/the-portability-of-aquadex-smartflowr-from-chf-solutions-could-mean-more-critically
https://www.nasdaq.com/press-release/baxter-to-present-at-the-bofa-securities-2021-virtual-health-care-conference-2021-04
https://www.nasdaq.com/press-release/baxter-to-host-its-annual-meeting-of-stockholders-in-virtual-format-2021-03-30
https://www.nasdaq.com/press-release/baxter-launches-initiative-to-increase-awareness-and-education-in-black-communities
https://www.nasdaq.com/press-release/baxter-to-host-first-quarter-2021-financial-results-conference-call-for-investors
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-closing-of-%2420.9-million-underwritten-public-offering-of
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-pricing-of-%2418.1-million-underwritten-public-offering-of
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-proposed-underwritten-public-offering-of-common-stock
https://www.nasdaq.com/press-release/baxter-announces-u.s.-fda-510k-clearance-of-ak-98-hemodialysis-machine-2021-03-12
https://www.nasdaq.com/press-release/chf-solutions-submits-patent-application-for-new-peripheral-venous-access-technology
https://www.nasdaq.com/press-release/baxter-to-present-at-oppenheimer-31st-annual-healthcare-conference-2021-03-10
https://www.nasdaq.com/press-release/chf-solutions-expands-access-to-ultrafiltration-therapy-for-pediatric-patients-in
https://www.nasdaq.com/press-release/baxter-biopharma-solutions-and-moderna-announce-agreement-for-fill-finish
https://www.nasdaq.com/press-release/chf-solutions-inc.-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-03
https://www.nasdaq.com/press-release/eras-2021%3a-chf-solutions-to-host-on-demand-presentation-on-management-of-fluid
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-49.5-percent-increase-in-revenue-for-fourth-quarter-2020
https://www.nasdaq.com/press-release/baxter-appoints-dr.-david-wilkes-to-its-board-and-albert-stroucken-as-lead
https://www.nasdaq.com/press-release/baxter-declares-quarterly-dividend-2021-02-16
https://www.nasdaq.com/press-release/chf-solutions-inc.-to-announce-fourth-quarter-2020-financial-results-on-march-2-2021
https://www.nasdaq.com/press-release/baxter-reports-fourth-quarter-and-full-year-2020-results-2021-02-04
https://www.nasdaq.com/press-release/chf-solutions-submits-patent-application-for-new-and-improved-diagnostic-parameters
https://www.nasdaq.com/press-release/chf-solutions-physician-led-webinar-highlights-real-world-evidence-supporting
https://www.nasdaq.com/press-release/baxter-to-present-at-svb-leerink-10th-annual-global-healthcare-conference-2021-01-21
https://www.nasdaq.com/press-release/chf-solutions-offers-educational-event-on-effective-fluid-management-strategies-in
https://www.nasdaq.com/press-release/chf-solutions-appoints-nestor-jaramillo-jr.-as-president-and-chief-executive-officer
https://www.nasdaq.com/press-release/chf-solutions-protects-new-peripheral-vascular-access-catheter-with-patent
https://www.nasdaq.com/press-release/baxter-biopharma-solutions-announces-sterile-manufacturing-agreement-for-novavax
https://www.nasdaq.com/press-release/baxter-to-host-fourth-quarter-2020-financial-results-conference-call-for-investors
https://www.nasdaq.com/press-release/baxter-to-present-at-the-39th-annual-j.p.-morgan-healthcare-conference-2020-12-16
https://www.nasdaq.com/press-release/chf-solutions-announces-meta-analysis-demonstrates-ultrafiltration-is-better-than
https://www.nasdaq.com/press-release/chf-solutions-announces-webinar-on-pediatric-ultrafiltration-therapy-hosted-by
https://www.nasdaq.com/press-release/baxter-and-adventhealth-tampa-announce-cost-savings-achieved-through-intraoperative
https://www.nasdaq.com/press-release/baxter-biopharma-solutions-announces-%2450-million-investment-to-expand-sterile-fill
https://www.nasdaq.com/press-release/chf-solutions-inc.-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2020-11
https://www.nasdaq.com/press-release/baxter-announces-u.s.-fda-510k-clearance-of-homechoice-claria-with-sharesource-2020
https://www.nasdaq.com/press-release/baxter-to-present-at-the-evercore-isi-3rd-annual-healthconx-virtual-conference-2020
https://www.nasdaq.com/press-release/baxter-declares-quarterly-dividend-2020-11-16
https://www.nasdaq.com/press-release/baxter-publishes-its-first-sustainability-accounting-standards-board-sasb-index-and
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-52-percent-increase-in-revenue-for-third-quarter-2020
https://www.nasdaq.com/press-release/chf-solutions-inc.-to-announce-third-quarter-2020-financial-results-on-november-10
https://www.nasdaq.com/press-release/baxter-announces-proposed-%24650-million-senior-notes-offering-2020-10-29
https://www.nasdaq.com/press-release/chf-solutions-announces-first-commercial-shipments-of-aquadex-systems-to-brazil
https://www.nasdaq.com/press-release/baxter-reports-third-quarter-2020-results-2020-10-29
https://www.nasdaq.com/press-release/baxter-supports-new-study-showing-blood-purification-with-oxiris-filter-set-can-play
https://www.nasdaq.com/press-release/chf-solutions-announces-deployment-of-aquadex-systems-to-hospitals-in-the-southeast
https://www.nasdaq.com/press-release/chf-solutions-submits-patent-application-to-improve-venous-blood-flow-and
https://www.nasdaq.com/press-release/baxter-to-present-at-the-29th-annual-credit-suisse-virtual-healthcare-conference-2020
https://www.nasdaq.com/press-release/baxter-supports-new-study-showing-nutritional-needs-in-critically-ill-covid-19
https://www.nasdaq.com/press-release/chf-solutions-announces-data-demonstrating-benefit-of-aquadex-therapy-for-treatment
https://www.nasdaq.com/press-release/chf-solutions-initiatives-at-hfsa-24th-annual-scientific-meeting-highlight-aquadex
https://www.nasdaq.com/press-release/baxter-announces-u.s.-fda-approval-of-clinimix-and-clinimix-e-with-higher-protein-for
https://www.nasdaq.com/press-release/chf-solutions-to-share-covid-19-experience-with-leading-government-commission-2020-09
https://www.nasdaq.com/press-release/baxter-announces-exclusive-distribution-agreement-with-biomerieux-for-novel-acute
https://www.nasdaq.com/press-release/chf-solutions-to-participate-at-lake-street-capital-markets-4th-annual-big4
https://www.nasdaq.com/press-release/chf-solutions-physician-led-webinar-concludes-fluid-overloaded-heart-failure-patients
https://www.nasdaq.com/press-release/correcting-and-replacing-baxter-to-host-third-quarter-2020-financial-results
https://www.nasdaq.com/press-release/chf-solutions-continues-physician-led-webinar-series-discussing-precise-management-of
https://www.nasdaq.com/press-release/chf-solutions-receives-180-day-extension-to-meet-nasdaq-minimum-bid-price-requirement
https://www.nasdaq.com/press-release/baxter-announces-u.s.-fda-de-novo-authorization-for-theranova-dialyzers-enabling-hdx
https://www.nasdaq.com/press-release/chf-solutions-applauds-u.s-congress-request-to-u.s.-international-trade-commission-to
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-closing-of-%2414.37-million-underwritten-public-offering
https://www.nasdaq.com/press-release/baxter-to-present-at-the-virtual-morgan-stanley-18th-annual-global-healthcare
https://www.nasdaq.com/press-release/baxter-to-present-at-the-2020-wells-fargo-virtual-healthcare-conference-2020-08-19
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-pricing-of-%2412.5-million-underwritten-public-offering
https://www.nasdaq.com/press-release/chf-solutions-aquadex-products-granted-federal-supply-schedule-contract-2020-08-18
https://www.nasdaq.com/press-release/baxter-obtains-u.s.-fda-emergency-use-authorization-for-regiocit-replacement-solution
https://www.nasdaq.com/press-release/baxter-obtains-u.s.-fda-emergency-use-authorizations-for-hf20-set-and-st-set-used-in
https://www.nasdaq.com/press-release/baxter-introduces-virtual-peritoneal-dialysis-excellence-academy-for-nurses-in-the-u
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-14-percent-increase-in-revenue-for-second-quarter-2020
https://www.nasdaq.com/press-release/chf-solutions-further-expands-commercial-presence-in-the-middle-east-with
https://www.nasdaq.com/press-release/baxter-reports-second-quarter-2020-results-2020-07-30
https://www.nasdaq.com/press-release/baxter-and-ayogo-announce-partnership-for-unique-digital-health-solutions-for-home
https://www.nasdaq.com/press-release/chf-solutions-inc.-to-announce-second-quarter-2020-financial-results-on-august-4-2020
https://www.nasdaq.com/press-release/baxter-and-vipun-medical-announce-collaboration-to-commercialize-innovative-gastric
https://www.nasdaq.com/press-release/chf-solutions-announces-registry-for-fluid-overload-conditions-in-pediatric-patients
https://www.nasdaq.com/press-release/baxter-ranks-in-top-10-on-2020-disability-equality-index-2020-07-15
https://www.nasdaq.com/press-release/baxter-declares-quarterly-dividend-2020-07-14
https://www.nasdaq.com/press-release/chf-solutions-continues-physician-led-webinar-series-with-focus-on-treatment-of-fluid
https://www.nasdaq.com/press-release/baxter-to-host-second-quarter-2020-financial-results-conference-call-for-investors
https://www.nasdaq.com/press-release/baxter-announces-u.s.-fda-clearance-of-altapore-shape-bioactive-bone-graft-for-use-in
https://www.nasdaq.com/press-release/chf-solutions-and-renalsense-enter-distribution-partnership-to-offer-ultrafiltration
https://www.nasdaq.com/press-release/moms-on-watch-troubled-by-mounting-allegations-at-prolacta-biosciences-2020-06-25
https://www.nasdaq.com/press-release/baxter-publishes-2019-corporate-responsibility-report-highlighting-efforts-to-make-a
https://www.nasdaq.com/press-release/chf-solutions-promotes-nestor-jaramillo-jr.-to-president-and-chief-operating-officer
https://www.nasdaq.com/press-release/chf-solutions-to-host-webinar-discussing-treatment-of-fluid-overload-in-pediatric
https://www.nasdaq.com/press-release/clinical-experts-discuss-fluid-management-strategies-in-critically-ill-covid-19
https://www.nasdaq.com/press-release/chf-solutions-to-host-webinar-discussing-fluid-management-strategies-in-critically
https://www.nasdaq.com/press-release/chf-solutions-ships-aquadex-smartflow-products-to-florida-for-use-with-covid-19
https://www.nasdaq.com/press-release/baxter-highlights-new-data-on-the-role-technologies-play-in-improving-care-for
https://www.nasdaq.com/press-release/chf-solutions-announces-the-launch-of-pediatric-ultrafiltration-therapy-using-the
https://www.nasdaq.com/press-release/baxter-to-present-at-the-goldman-sachs-41st-annual-global-healthcare-conference
https://www.nasdaq.com/press-release/chf-solutions-expands-commercial-presence-in-the-middle-east-with-distribution
https://www.nasdaq.com/press-release/chf-solutions-inc.-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2020-05
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-adjournment-of-annual-meeting-of-stockholders-2020-05-22
https://www.nasdaq.com/press-release/baxter-receives-ce-marking-and-australian-regulatory-approval-for-evo-iq-syringe
https://www.nasdaq.com/press-release/publication-highlights-use-of-ultrafiltration-for-fluid-management-in-covid-19
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-34-percent-increase-in-revenue-for-first-quarter-2020
https://www.nasdaq.com/press-release/baxter-announces-results-of-clinical-trial-on-benefits-of-dynamic-fluid-management-in
https://www.nasdaq.com/press-release/baxter-increases-dividend-and-declares-quarterly-dividend-2020-05-05
https://www.nasdaq.com/press-release/chf-solutions-inc.-to-announce-first-quarter-2020-financial-results-on-may-12-2020
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-registered-direct-offering-priced-at-the-market-2020-05
https://www.nasdaq.com/press-release/chf-solutions-ships-aquadex-product-to-covid-19-specialty-center-in-minnesota-2020-05
https://www.nasdaq.com/press-release/baxter-reports-first-quarter-2020-results-2020-04-30
https://www.nasdaq.com/press-release/baxter-to-present-at-the-ubs-virtual-global-healthcare-conference-2020-04-27
https://www.nasdaq.com/press-release/baxter-to-present-at-the-virtual-bofa-securities-2020-health-care-conference-2020-04
https://www.nasdaq.com/press-release/baxter-obtains-u.s.-fda-emergency-use-authorization-for-oxiris-blood-purification
https://www.nasdaq.com/press-release/chf-solutions-ships-first-commercial-orders-of-aquadex-smartflowtm-system-to-austria
https://www.nasdaq.com/press-release/chf-solutions-receives-%241.66-million-under-sbas-paycheck-protection-program-and-%241.1
https://www.nasdaq.com/press-release/baxter-to-host-first-quarter-2020-financial-results-conference-call-for-investors
https://www.nasdaq.com/press-release/chf-solutions-announces-300-increase-in-utilization-of-aquadex-therapy-in-nyc
https://www.nasdaq.com/press-release/baxter-provides-update-on-covid-19-response-efforts-2020-04-15
https://www.nasdaq.com/press-release/chf-solutions-announces-covid-19-patients-treated-with-aquadex-therapy-for-fluid-0
https://www.nasdaq.com/press-release/chf-solutions-submits-patent-application-for-hemofiltration-system-for-rapid-clearing
https://www.nasdaq.com/press-release/chf-solutions-convene-physicians-to-discuss-cardio-pulmonary-renal-management-of
https://www.nasdaq.com/press-release/chf-solutions-doubles-production-staff-of-aquadex-smartflowtm-consoles-due-to
https://www.nasdaq.com/press-release/baxter-to-host-its-annual-meeting-of-stockholders-in-virtual-format-2020-04-01
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-pricing-of-registered-direct-offering-priced-at-the-0
https://www.nasdaq.com/press-release/chf-solutions-announces-covid-19-patients-treated-with-aquadex-therapy-for-fluid
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-pricing-of-registered-direct-offering-2020-03-20
https://www.nasdaq.com/press-release/chf-solutions-aquadex-flexflowr-system-is-licensed-and-approved-for-sale-in-india
https://www.nasdaq.com/press-release/chf-solutions-webinar-highlighted-importance-of-fluid-management-in-patients-treated
https://www.nasdaq.com/press-release/baxter-reports-fourth-quarter-and-full-year-2019-results-completes-financial
https://www.nasdaq.com/press-release/chf-solutions-to-host-clinician-webinar-on-use-of-ultrafiltration-for-volume
https://www.nasdaq.com/press-release/baxter-to-host-fourth-quarter-2019-financial-results-conference-call-for-investors
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-fourth-quarter-financial-results-and-provides-company
https://www.nasdaq.com/press-release/baxter-launches-peri-strips-dry-with-secure-grip-technology-for-reliable-staple-line
https://www.nasdaq.com/press-release/chf-solutions-receives-510k-clearance-for-aquadex-smartflowtm-system-in-pediatric
https://www.nasdaq.com/press-release/chf-solutions-inc.-to-announce-fourth-quarter-and-year-end-2019-financial-results-on
https://www.nasdaq.com/press-release/baxter-to-present-at-the-raymond-james-41st-annual-institutional-investors-conference
https://www.nasdaq.com/press-release/baxter-declares-quarterly-dividend-2020-02-18
https://www.nasdaq.com/press-release/baxter-completes-acquisition-of-seprafilm-adhesion-barrier-2020-02-18
https://www.nasdaq.com/press-release/chf-solutions-expands-commercial-presence-in-europe-with-distribution-arrangement-for
https://www.nasdaq.com/press-release/baxter-and-cosmed-announce-u.s.-fda-510k-clearance-of-q-nrg-indirect-calorimetry
https://www.nasdaq.com/press-release/chf-solutions-inc.-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2020-02
https://www.nasdaq.com/press-release/chf-solutions-receives-ce-mark-for-its-new-aquadex-smartflowtm-console-2020-02-05
https://www.nasdaq.com/press-release/baxter-and-spectral-medical-announce-exclusive-distribution-agreement-for-blood
https://www.nasdaq.com/press-release/chf-solutions-expands-its-patent-portfolio-with-four-applications-for-innovations-for
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-closing-of-%249.66-million-underwritten-public-offering
https://www.nasdaq.com/press-release/chf-solutions-inc.-announces-pricing-of-%248.4-million-underwritten-public-offering
https://www.nasdaq.com/press-release/chf-solutions-announces-launch-of-aquapheresis-therapy-using-aquadex-flexflowr-system
https://www.nasdaq.com/press-release/baxter-to-present-at-the-9th-annual-svb-leerink-global-healthcare-conference-2020-01
https://www.nasdaq.com/press-release/baxter-announces-preliminary-net-sales-for-the-fourth-quarter-and-full-year-2019-and
https://www.nasdaq.com/press-release/shareholder-alert%3a-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-69
https://www.nasdaq.com/press-release/lead-plaintiff-deadline%3a-johnson-fistel-llp-encourages-investors-to-contact-the-4
https://www.nasdaq.com/press-release/chf-solutions-announces-presentation-of-clinical-data-with-aquadex-flexflowr
https://www.nasdaq.com/press-release/bragar-eagel-squire-p.c.-reminds-investors-that-class-action-lawsuits-have-been-3
https://www.nasdaq.com/press-release/baxter-to-present-at-the-38th-annual-j.p.-morgan-healthcare-conference-2019-12-04
https://www.nasdaq.com/press-release/chf-solutions-announces-launch-of-ultrafiltration-therapy-using-aquadex-flexflowr
https://www.nasdaq.com/press-release/rosen-a-highly-ranked-firm-announces-filing-of-securities-class-action-lawsuit
https://www.nasdaq.com/press-release/baxter-to-expand-advanced-surgery-portfolio-with-acquisition-of-seprafilm-adhesion
https://www.nasdaq.com/press-release/investor-alert-baxter-international-inc.-bax-bronstein-gewirtz-grossman-llc-notifies
https://www.nasdaq.com/press-release/hagens-berman-national-trial-attorneys-encourages-baxter-international-bax-investors
https://www.nasdaq.com/press-release/kessler-topaz-meltzer-check-llp-files-a-shareholder-class-action-lawsuit-against-0
https://www.nasdaq.com/press-release/baxter-receives-nyse-notice-regarding-delayed-form-10-q-filing-2019-11-22
https://www.nasdaq.com/press-release/baxter-declares-quarterly-dividend-2019-11-19
https://www.nasdaq.com/press-release/chf-solutions-inc.-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2019-11
https://www.nasdaq.com/press-release/baxter-to-present-at-the-evercore-isi-2nd-annual-healthconx-conference-2019-11-06
https://www.nasdaq.com/press-release/baxter-and-ayogo-launch-ckdme-patient-empowering-digital-education-tool-at-kidney
https://www.nasdaq.com/press-release/baxter-international-investigation-initiated-by-former-louisiana-attorney-general%3a
https://www.nasdaq.com/press-release/hagens-berman-national-trial-attorneys-notifies-baxter-international-bax-investors-of
https://www.nasdaq.com/press-release/investor-alert%3a-kaplan-fox-investigates-baxter-international-inc.-nyse%3a-bax-2019-10
https://www.nasdaq.com/press-release/investor-alert%3a-ademi-oreilly-llp-investigates-possible-securities-fraud-of-baxter
